Bryan Sendrowski

Bryan Sendrowski is a Partner on the External Operations team at Deerfield and joined the Firm in 2012. He is responsible for the day to day oversight and management of certain investments in Deerfield’s Private Design and Healthcare Innovations Funds. Prior to joining Deerfield, Mr. Sendrowski was Chief Financial Officer of New American Therapeutics, a specialty pharmaceutical company that was funded and facilitated by Deerfield’s Private Design Funds. Before New American Therapeutics, he was Chief Financial Officer at Akrimax Pharmaceuticals and Vice President and Controller of Reliant Pharmaceuticals. He also previously served as a Senior Manager in the financial statement audit practice of KPMG, LLP with responsibility for the management of public and private company audits. Mr. Sendrowski received his B.A. from Pace University and is licensed (inactive) as a Certified Public Accountant in the state of New Jersey.